Skip to main content
Caplight Logo









Preview Health

Preview Health

Private
SydneyHealthcare & Life Scienceshttps://www.preview.health/

Last Round

Accelerator

May 20, 2025

Total Funding Raised

$167,000

Company Overview

Preview Health is a healthcare technology company that has developed an AI-powered molecular profiling platform designed for precision medicine.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Precision Medicine, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

metabolomics platformAI-powered metabolomicsprecision medicinemolecular fingerprintingbiomarker discoverydrug response profilingclinical trial supportmetabolite analysisearly disease detectionAI diagnosticsCRO servicesParkinson's disease testmass spectrometrybrain health analysis

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Preview Health Comparables

Compare Preview Health with similar companies based on industry and business-model similarity.

Preview Health comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sapient
85%
Dalton Bioanalytics
82%
Arome Science Inc.
81%

Preview Health Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorMay 20, 2025

Key People

Founding team and executive leadership

Diana Zhang

Founder & CEO

Founding Team

Preview Health Investors

Notable investors and investment history

Preview Health investors
InvestorRounds
Australian Medical AngelsAccelerator
PharmStarsAccelerator
UNSW FoundersAccelerator
Blackbird VenturesGrant
The George Institute for Global HealthAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 20, 2025

    $100K round led by PharmStars Ventures Fund.

  • Feb 24, 2025

    Monthly visitors increased 50% MoM.

Preview Health Filings

Explore SEC and related filing metadata, where available.

Preview Health filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Preview Health's valuation, stock price, and market status.

Is Preview Health a public or private company?

Preview Health is a private company.

What is the current stock price of Preview Health?

Preview Health is a private company with no public stock price. No recent secondary market data is available.

How much is Preview Health worth (valuation)?

Valuation information for Preview Health is not publicly available.

Can I buy Preview Health stock?

Preview Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Preview Health's last funding round?

Preview Health's most recent funding round was Accelerator on May 20, 2025.

Who are the main investors in Preview Health?

Key investors in Preview Health include PharmStars.

Will Preview Health IPO soon?

No public IPO plans have been announced for Preview Health.

How can I track Preview Health secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Preview Health's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSydney
Employee Range6
Year Founded2023
Last FundingMay 20, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?